Steinunn Thorlacius

Title: Steinunn Thorlacius: Innovator in Cancer Genetics

Introduction

Steinunn Thorlacius is a prominent inventor based in Reykjavik, Iceland. She has made significant contributions to the field of genetics, particularly in the area of cancer predisposition. Her work focuses on identifying genetic markers that can help in the early detection of certain types of cancer.

Latest Patents

Steinunn Thorlacius holds a patent for her invention titled "Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition." This patent highlights the discovery that specific polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention outlines diagnostic applications for determining cancer susceptibility using these markers, as well as kits designed for such applications.

Career Highlights

Steinunn is associated with Decode Genetics ehf, a company known for its pioneering work in genetic research. Her role at the company has allowed her to contribute to groundbreaking studies that enhance our understanding of genetic factors in cancer.

Collaborations

Steinunn has collaborated with notable colleagues, including Patrick Sulem and Julius Gudmundsson. Their combined expertise has further advanced research in the field of cancer genetics.

Conclusion

Steinunn Thorlacius is a key figure in the realm of genetic research, particularly in relation to cancer predisposition. Her innovative work continues to pave the way for advancements in diagnostic applications and cancer prevention strategies.